| NDC Code | 70257-053-51 |
|---|
| Package Description | 1 VIAL, GLASS in 1 CARTON (70257-053-51) / 1 mL in 1 VIAL, GLASS (70257-053-11) |
|---|
| Product NDC | 70257-053 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Hepagam B |
|---|
| Non-Proprietary Name | Human Hepatitis B Virus Immune Globulin |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS |
|---|
| Start Marketing Date | 20180620 |
|---|
| End Marketing Date | 20240430 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125035 |
|---|
| Manufacturer | Saol Therapeutics Inc. |
|---|
| Substance Name | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
|---|
| Strength | 312 |
|---|
| Strength Unit | [iU]/mL |
|---|
| Pharmacy Classes | Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT] |
|---|